Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net Loss	$ (7,348,851)	$ (10,150,082)
Adjustments to reconcile Net Loss to Net Cash used by operations:
Depreciation and amortization	3,588,966	2,957,337
Debt discount amortization	325,141	24,144
Employee stock awards	716,589	688,750
Stock grants	213,130	548,058
Stock for services	87,500	272,000
Contingent consideration payable fair value	(88,106)
Interest on convertible promissory notes	146,104
Allowance for doubtful accounts	54,846	(124,313)
Reduction in right of use asset	322,970
Paycheck protection program note forgiveness	(624,600)
Loss on disposal of assets	25,400
Stock issued in lieu of cash payments	48,000
Loss on Jagemann Munition Components	1,000,000
Stock and warrants for note conversion	1,315,494
Changes in Current Assets and Liabilities
Accounts receivable	(3,927,054)	91,995
Due to (from) related parties	150	2,858
Inventories	(5,140,518)	(250,383)
Prepaid expenses	16,985	301,241
Deposits	164,388	(93,830)
Accounts payable	1,842,472	2,357,708
Accrued liabilities	2,332,819	271,063
Operating lease liability	(322,037)
Net cash used in operating activities	(5,250,212)	(3,103,454)
Cash flows from investing activities
Purchase of equipment	(4,493,051)	(356,022)
Net cash used in investing activities	(4,493,051)	(356,022)
Cash flow from financing activities
Proceeds from inventory facility	2,250,000
Proceeds from factoring liability	26,079,000	936,750
Payments on factoring liability	(25,794,381)
Proceeds from paycheck protection program notes	1,051,985
Proceeds from note payable related party issued	3,500,000	415,000
Payments on note payable - related party	(7,235,312)	(1,500,000)
Payments on insurance premium note payment	(452,471)	(322,209)
Proceeds from note payable	4,000,000
Proceeds from convertible promissory notes	1,959,000
Sale of common stock	23,564,619	2,465,540
Common stock issued for exercised warrants	2,288,878
Common stock issuance costs	(3,344,436)	(285,981)
Contingent consideration payment		(300,000)
Net cash provided by financing activities	27,866,882	1,409,100
Net increase/(decrease) in cash	18,123,619	(2,050,376)
Cash, beginning of period	884,274	2,181,246
Cash, end of period	19,007,893	130,870
Supplemental cash flow disclosures
Cash paid during the period for - Interest	923,454	346,800
Cash paid during the period for - Income taxes
Non-cash investing and financing activities:
Accounts payable	(2,635,797)
Note payable related party	2,635,797
Right of use assets - operating leases	(737,680)	(4,168,771)
Operating lease liability	737,680	4,168,771
Insurance premium note payment	226,539	165,120
Prepaid expenses	(226,539)	(165,120)
Convertible promissory note	(3,520,000)
Note issuance costs	(208,855)
Convertible promissory note conversion	3,728,855	318,226
Convertible promissory note and accrued interest		(318,226)
Note payable related party conversion	2,100,000
Note payable related party	(2,100,000)	(2,596,200)
Other intangible assets		2,312,609
Deposits		(109,250)
Equipment		392,841
Stock subscription receivable	(664,975)
Common stock	310
Additional paid-in capital	664,665
Total non-cash investing and financing activities